HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Niemann-Pick type C1 project team

Scientist-Patient Advocate Team Advances NPC1 Research

Patient-focused collaboration among government and academic scientists enabled the advance of a potential treatment for the rare disease Niemann-Pick type C1.

A 2017 Rare Disease Day at NIH exhibitor speaks to an event participant.

View Photos from Rare Disease Day at NIH

Thank you to all who participated in the 2017 NIH event.

Differentiating neurons derived from induced pluripotent stem cells.

NCATS Seeks Stem Cell Translation Collaborators

NCATS seeks stem cell research collaborators from the biotechnology, pharmaceutical, and NIH intramural and extramural communities.

Doctor examining small child being held by her mother.

New Funding Opportunities to Repurpose Drugs

NCATS has announced funding opportunities to repurpose existing drugs through public-private partnerships.

NCATS e-newsletter displayed on a tablet

February E-Newsletter Now Available

Read about NCATS’ new funding opportunity announcement to repurpose existing drugs, Rare Disease Day at NIH, CTSA Program collaborations, and more.

Scientist-Patient Advocate Team Advances NPC1 Research

Patient-focused collaboration among government and academic scientists enabled the advance of a potential treatment for the rare disease Niemann-Pick type C1.

Niemann-Pick type C1 project team

View Photos from Rare Disease Day at NIH

Thank you to all who participated in the 2017 NIH event.

A 2017 Rare Disease Day at NIH exhibitor speaks to an event participant.

NCATS Seeks Stem Cell Translation Collaborators

NCATS seeks stem cell research collaborators from the biotechnology, pharmaceutical, and NIH intramural and extramural communities.

Differentiating neurons derived from induced pluripotent stem cells.

February E-Newsletter Now Available

Read about NCATS’ new funding opportunity announcement to repurpose existing drugs, Rare Disease Day at NIH, CTSA Program collaborations, and more.

NCATS e-newsletter displayed on a tablet

New Funding Opportunities to Repurpose Drugs

NCATS has announced funding opportunities to repurpose existing drugs through public-private partnerships.

Doctor examining small child being held by her mother.

More Center News

Mining Biomedical Literature

NCATS-supported researchers recruit citizen scientists to help.

Moving Technologies to the Marketplace

I-Corps training helps NCATS-supported companies.

  • Facebook icon
  • Twitter icon
  • YouTube icon

View Rare Disease Patient Videos

Alani, a girl who has congenital generalized lipodystrophy

Watch rare disease patients and caregivers talk about the challenges they face and how NIH’s collaborative research efforts offer hope. View the videos.

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.

  • NCATS Programs & Initiatives
    NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
  • Small Business Opportunities
    NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
  • Expertise & Resources
    NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
  • Licensing Opportunities
    NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.